FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891433834> ?p ?o ?g. }

• W2891433834 endingPage "1979" @default.
• W2891433834 startingPage "1965" @default.
• W2891433834 abstract "Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer. Despite the development of novel targeted and immune therapies, the 5-year survival rate is still only 21%, indicating the need for more efficient treatment regimens. Lysine-specific demethylase 1 (LSD1) is an epigenetic eraser that modifies histone 3 methylation status, and is highly overexpressed in LUAD. Using representative human cell culture systems and two autochthonous transgenic mouse models, we investigated inhibition of LSD1 as a novel therapeutic option for treating LUAD. The reversible LSD1 inhibitor HCI-2509 significantly reduced cell growth with an IC50 of 0.3-5 μmin vitro, which was linked to an enhancement of histone 3 lysine methylation. Most importantly, growth arrest, as well as inhibition of the invasion capacities, was independent of the underlying driver mutations. Subsequent expression profiling revealed that the cell cycle and replication machinery were prominently affected after LSD1 inhibition. In addition, our data provide evidence that LSD1 blockade significantly interferes with EGFR downstream signaling. Finally, our in vitro results were confirmed by preclinical therapeutic approaches, including the use of two autochthonous transgenic LUAD mouse models driven by either EGFR or KRAS mutations. Importantly, LSD1 inhibition resulted in significantly lower tumor formation and a strong reduction in tumor progression, which were independent of the underlying mutational background of the mouse models. Hence, our findings provide substantial evidence indicating that tumor growth of LUAD can be markedly decreased by HCI-2509 treatment, suggesting its use as a single agent maintenance therapy or combined therapeutical application in novel concerted drug approaches." @default.
• W2891433834 created "2018-09-27" @default.
• W2891433834 creator A5003324655 @default.
• W2891433834 creator A5006712577 @default.
• W2891433834 creator A5020690168 @default.
• W2891433834 creator A5032585201 @default.
• W2891433834 creator A5042257192 @default.
• W2891433834 creator A5051988731 @default.
• W2891433834 creator A5052956337 @default.
• W2891433834 creator A5058914166 @default.
• W2891433834 creator A5060134952 @default.
• W2891433834 creator A5060543893 @default.
• W2891433834 creator A5064023616 @default.
• W2891433834 creator A5067469715 @default.
• W2891433834 creator A5068679022 @default.
• W2891433834 creator A5078248666 @default.
• W2891433834 creator A5089043236 @default.
• W2891433834 date "2018-10-13" @default.
• W2891433834 modified "2023-10-11" @default.
• W2891433834 title "Preclinical studies reveal that <scp>LSD</scp> 1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations" @default.
• W2891433834 cites W1603797292 @default.
• W2891433834 cites W1611210979 @default.
• W2891433834 cites W1795095761 @default.
• W2891433834 cites W1954584384 @default.
• W2891433834 cites W1976343579 @default.
• W2891433834 cites W1980673831 @default.
• W2891433834 cites W1980808675 @default.
• W2891433834 cites W1986193427 @default.
• W2891433834 cites W1992323285 @default.
• W2891433834 cites W2005253752 @default.
• W2891433834 cites W2006229882 @default.
• W2891433834 cites W2008637251 @default.
• W2891433834 cites W2009029095 @default.
• W2891433834 cites W2013149980 @default.
• W2891433834 cites W2015850802 @default.
• W2891433834 cites W2019712140 @default.
• W2891433834 cites W2026283316 @default.
• W2891433834 cites W2043509228 @default.
• W2891433834 cites W2054621094 @default.
• W2891433834 cites W2057437339 @default.
• W2891433834 cites W2067448271 @default.
• W2891433834 cites W2069534609 @default.
• W2891433834 cites W2090029719 @default.
• W2891433834 cites W2102156431 @default.
• W2891433834 cites W2117247812 @default.
• W2891433834 cites W2120450507 @default.
• W2891433834 cites W2126181231 @default.
• W2891433834 cites W2130211801 @default.
• W2891433834 cites W2133488997 @default.
• W2891433834 cites W2137678309 @default.
• W2891433834 cites W2154969724 @default.
• W2891433834 cites W2163188200 @default.
• W2891433834 cites W2166419831 @default.
• W2891433834 cites W2169347571 @default.
• W2891433834 cites W2202769927 @default.
• W2891433834 cites W2207941545 @default.
• W2891433834 cites W2235523093 @default.
• W2891433834 cites W2335573407 @default.
• W2891433834 cites W2342737942 @default.
• W2891433834 cites W2414908314 @default.
• W2891433834 cites W2460507268 @default.
• W2891433834 cites W2554694872 @default.
• W2891433834 cites W2554954289 @default.
• W2891433834 cites W2586445984 @default.
• W2891433834 cites W2625567395 @default.
• W2891433834 cites W2746372498 @default.
• W2891433834 cites W2760255113 @default.
• W2891433834 cites W2766289573 @default.
• W2891433834 cites W2771438132 @default.
• W2891433834 cites W2791963264 @default.
• W2891433834 doi "https://doi.org/10.1002/1878-0261.12382" @default.
• W2891433834 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6210049" @default.
• W2891433834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30220105" @default.
• W2891433834 hasPublicationYear "2018" @default.
• W2891433834 type Work @default.
• W2891433834 sameAs 2891433834 @default.
• W2891433834 citedByCount "24" @default.
• W2891433834 countsByYear W28914338342019 @default.
• W2891433834 countsByYear W28914338342020 @default.
• W2891433834 countsByYear W28914338342021 @default.
• W2891433834 countsByYear W28914338342022 @default.
• W2891433834 countsByYear W28914338342023 @default.
• W2891433834 crossrefType "journal-article" @default.
• W2891433834 hasAuthorship W2891433834A5003324655 @default.
• W2891433834 hasAuthorship W2891433834A5006712577 @default.
• W2891433834 hasAuthorship W2891433834A5020690168 @default.
• W2891433834 hasAuthorship W2891433834A5032585201 @default.
• W2891433834 hasAuthorship W2891433834A5042257192 @default.
• W2891433834 hasAuthorship W2891433834A5051988731 @default.
• W2891433834 hasAuthorship W2891433834A5052956337 @default.
• W2891433834 hasAuthorship W2891433834A5058914166 @default.
• W2891433834 hasAuthorship W2891433834A5060134952 @default.
• W2891433834 hasAuthorship W2891433834A5060543893 @default.
• W2891433834 hasAuthorship W2891433834A5064023616 @default.
• W2891433834 hasAuthorship W2891433834A5067469715 @default.
• W2891433834 hasAuthorship W2891433834A5068679022 @default.
• W2891433834 hasAuthorship W2891433834A5078248666 @default.
• W2891433834 hasAuthorship W2891433834A5089043236 @default.

• next